Severe mental illness and substance misuse (dual diagnosis) community health and social care services Committee meeting Date: 1/2/2016 & 2/2/2016 Location: Minutes: NICE Manchester offices, Bollin Room, Level 1A,City Tower, Piccadilly Plaza, Manchester M1 4BT Final Committee members present: Alan Maryon-Davis (Chair) (Present for items 1 Rachel Johns (Vice Chair) (Present for items 1 Jo Cooke (Present for items 1 Brendan Collins (Present for items 9 Jakki Cowley (Present for items 1 Sarah Newsham (Present for items 1 Jane West (Present for items 1 Richard Watt (Present for items 1 8) Alyson Burberry (Topic expert member) (Present for items 1 Dee Cunniffe (Topic expert member) (Present for items 1 Jane Marshall (Topic expert member) (Present for items 1 Luke Mitcheson (Topic expert member) (Present for items 1 Rob O Brien (Topic expert member) (Present for items 1 In attendance: Caroline Mulvihill Technical Lead, NICE (Present for items 1 Page 1 of 6
Lakshmi Murthy Senior Technical Analyst, NICE (Present for items 1 Alastair Fischer Health Economist, NICE (Present for items 1 5) Denise Jarrett Assistant Project Manager, NICE (Present for items 1 Jaimella Espley Senior Medical Editor, NICE (Present for items 1 8) Sonia Johnson Ciara Donnelly Astrid Aregui Director, Division of Psychiatry, University College of London Senior Business Analyst, NICE Senior Digital Editor, NICE (By teleconference for item 5) (Present for item 10) (Present for item 10) Observers: Ciara Donnelly (Present for items 1 8, 11 Andrew Buckley (Present for items 8, 14 Andrew Harding (Present for items 11 Astrid Aregui (Present for items 11 Apologies: Graham Rushbrook Committee member 1. Welcome and objectives for the meeting The Chair welcomed the Committee members and attendees to the fifth meeting on health and social care services. The Committee members and attendees introduced themselves. No members of the public asked to observe the meeting. The Chair informed the Committee that apologies had been received. These are noted above. The Chair outlined the objectives of the meeting, which included: Hear and discuss expert testimony in the area of early intervention services Review the guideline document and the comments received on the draft Page 2 of 6
recommendations from the committee members Agree draft recommendations, the evidence gaps and research recommendations 2. Confirmation of matter under discussion, and declarations of interest The Chair confirmed that, for the purpose of managing conflicts of interest, the matter under discussion was service organisation and delivery of wider health and social care needs of people with a severe mental illness combined with misuse of substance. The Chair asked everyone to verbally declare any interests that have arisen since the last meeting. Name Job title, organisation Declarations of Interest, date declared Decision taken Sonia Johnson Director UCL Division of Psychiatry University College London Funded by the National Institute for Health Research (NIHR) as chief investigator in the CIRCLE trial, a multicentre investigation of the effectiveness of a contingency management intervention for cannabis use Declare and participate Luke Mitcheson Consultant Clinical Psychologist, South London and Maudsley NHS Foundation Trust Seconded to PHE from his NHS employer (SLAM) for one day a week to provide clinical advice. In this role, he is a member of the Dual Diagnosis Expert Reference Group and has provided advice on developing the PHE guidance on co-existing alcohol and drug misuse with mental health issues. Declare and participate The Chair and a senior member of the Developer s team noted that the interests declared did not prevent the attendees from fully participating in the meeting. Page 3 of 6
3. Minutes of last meeting The Chair asked the Committee if it wanted any changes made to the minutes of the last meeting. The Committee agreed that the minutes were a true and accurate account of the meeting. The Chair confirmed that all matters arising had been completed or were in hand. 4. Discussion The committee discussed the draft guidance currently being prepared by Public Health England on Co-existing alcohol and drug misuse with mental health issues. 5. Presentations The Chair introduced Sonia Johnson, Director UCL Division of Psychiatry who provided expert testimony to the committee on the topic of early intervention services. Sonia took questions from the group. The Committee then discussed the issues presented in relation to this guideline. The Chair thanked Sonia for her presentation. The Chair introduced Alastair Fischer, Technical Advisor (Economics), NICE who provided a summary of the cost effectiveness evidence that had been presented to the committee at previous meetings. The Chair thanked Alastair for his presentation. The Chair introduced Jaimella Espley, Senior Medical Editor, NICE who gave a presentation on writing recommendations for NICE guidelines and the role of the NICE Editors. The Committee discussed the issues presented and the Chair thanked Jaimella for her presentation. The Committee thanked Sonia, Alastair and Jaimella for their presentations and contribution to the development of the guideline. Page 4 of 6
6. Questions and discussion The Committee discussed the presentations they had received and their implications on the draft guideline. 7. Recommendations development The Committee reviewed the recommendations that they had drafted at previous meetings and made amendments to them based on the evidence presented and further discussion. 8. Any other business There were no additional matters arising. The Chair thanked the group for their work and closed the first day of the meeting. Day 2 9. Welcome and objectives for the meeting The Chair welcomed the Committee to the second day of the meeting. 10. Confirmation of matter under discussion, and declarations of interest The Chair confirmed that, for the purpose of managing conflicts of interest, the matter under discussion was service organisation and delivery of wider health and social care needs of people with a severe mental illness combined with misuse of substance. The Chair asked everyone to verbally declare any interests that have arisen since the last meeting There were no further declarations made. 11. Finalising guideline recommendations and committee discussion sections The Committee continued to review and finalise their draft recommendations and make further changes to them. 12. Research recommendations The Committee considered the gaps in the evidence that was presented and made suggestions for areas for future research. Page 5 of 6
13. Presentations The Chair introduced Astrid Aregui, Senior Digital Editor, NICE, who gave a presentation on NICE Pathways The Committee discussed the issues presented and the Chair thanked Astrid for her presentation. The Chair introduced Ciara Donnelly, Senior Business Analyst, NICE who gave a presentation on Resource Impact Assessment The Committee discussed the issues presented in relation to this guideline. The Chair thanked Ciara for her presentation. The Committee thanked Astrid and Ciara for their presentations and contributions to the development of the guideline. 14. Finalising draft recommendations and reviewing all sections of the guideline Following discussion, the Committee identified gaps in the evidence and finalised the research recommendations. 15. Next steps Lakshmi Murthy set out the next steps in the process. 16. Any other business There were no additional matters arising. The Chair thanked the group for their work and closed the meeting. Date of next meeting: 18/07/2016 & 19/07/2016 Location of next meeting: NICE Manchester office, Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT Page 6 of 6